Compare Humana Inc (HUM) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Taskus Inc — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Taskus Inc trades at $8.14 (market cap $723.41M). The key difference: Humana Inc is far larger — about 64.3× Taskus Inc's market cap, and Humana Inc pays a 0.91% dividend while Taskus Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Taskus Inc for 34 Days on average.
| HUM | TASK | |
|---|---|---|
Market Cap | $46.49B | $723.41M |
Volume | 2,567,704 | 201,303 |
Sector | Health | Technology |
52-Week High | $431.03 | $14.30 |
52-Week Low | $163.67 | $4.57 |
Typical Hold Time | 51 Days | 34 Days |
Enterprise Value | $53.84B | $1.09B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
TaskUs trades at $8.01, up 1.52% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings beat with revenue of $308.9M, though Q1 missed expectations. Fundamentals show attractive valuation with P/E of 6.8 and robust profitability metrics including 8.75% net margin and 25.43% ROE. Revenue growth continues at 5% year-over-year, driven by AI services expansion offsetting declines in legacy segments.
The stock presents value opportunity with 16% upside to consensus price target of $9.33, supported by 55% analyst buy ratings. Key risks include margin compression from labor costs and client concentration. Institutional ownership increased with Dimensional Fund Advisors raising stake by 12.8% in Q1 2026. Near-term catalyst is Q3 earnings where company must deliver on $0.30 EPS expectations to maintain momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
